5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats
- PMID: 2107558
- DOI: 10.1007/BF02244609
5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats
Abstract
The functional role of brain 5-HT and 5-HT receptor subtypes in periaqueductal gray (PAG) induced aversion has been investigated in rats. Antiaversive effects were found with the serotonin agonists TFMPP, mCPP and DOI but not with RU 24969 which was found to facilitate PAG aversion. The first three serotonin agonists share potent 5-HT1C activity while RU 24969 differs with a high 5-HT1A activity. Proaversive effects were found with the mixed 5-HT1C/5-HT2 antagonists cyproheptadine and ritanserin; this effect was already reported for the mixed 5-HT1C/5-HT2 antagonists metergoline and mianserin and is opposite to the effects of the selective 5-HT2 antagonists ketanserin, pirenperone, trazodone and spiperone. The antiaversive effects of mCPP (1 mg/kg) could be prevented by pretreatment of the animals with mianserin (1 and 10 mg/kg). These results suggest that 5-HT1C receptors play an important role in the serotonergic control of PAG aversion. 5-HT1C receptor activation seems to mediate antiaversive effects whereas acute 5-HT1C receptor blockade appears to facilitate PAG aversion. Functional interactions take place between several receptor types in the in vivo control of PAG aversion, where 5-HT1C receptors appear to play a predominant function.
Similar articles
-
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.Br J Pharmacol. 1988 May;94(1):137-47. doi: 10.1111/j.1476-5381.1988.tb11508.x. Br J Pharmacol. 1988. PMID: 3401632 Free PMC article.
-
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.Psychopharmacology (Berl). 1988;96(1):93-100. doi: 10.1007/BF02431539. Psychopharmacology (Berl). 1988. PMID: 2906446
-
Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.Eur J Pharmacol. 1990 Oct 23;187(3):435-43. doi: 10.1016/0014-2999(90)90370-l. Eur J Pharmacol. 1990. PMID: 2127400
-
5-HT2 receptor antagonists and migraine therapy.J Neurol. 1991;238 Suppl 1:S45-52. doi: 10.1007/BF01642906. J Neurol. 1991. PMID: 2045831 Review.
-
Centrally active 5-HT receptor agonists and antagonists.Neurosci Biobehav Rev. 1992 Spring;16(1):75-82. doi: 10.1016/s0149-7634(05)80054-5. Neurosci Biobehav Rev. 1992. PMID: 1553108 Review.
Cited by
-
5HT drugs in animal models of anxiety.Psychopharmacology (Berl). 1993;112(1):13-20. doi: 10.1007/BF02247358. Psychopharmacology (Berl). 1993. PMID: 7871002 Review.
-
Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.Br J Pharmacol. 1991 Dec;104(4):1038-44. doi: 10.1111/j.1476-5381.1991.tb12546.x. Br J Pharmacol. 1991. PMID: 1687364 Free PMC article.
-
Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats.J Neural Transm Gen Sect. 1992;87(2):87-96. doi: 10.1007/BF01245010. J Neural Transm Gen Sect. 1992. PMID: 1348421
-
Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray.Psychopharmacology (Berl). 1992;108(1-2):110-4. doi: 10.1007/BF02245294. Psychopharmacology (Berl). 1992. PMID: 1410130
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources